VYNE Therapeutics Inc (VYNE)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 126k | 167k | 6k | 99k | 135k | 114k | 76k | 98k |
| Operating Income | -8.29M | -9.33M | -7.98M | -5.88M | -10.32M | -6.23M | -6.83M | -7.38M |
| Pre Tax Income | -8.24M | -9.26M | -7.75M | -5.61M | -10.04M | -6.07M | -6.15M | -6.24M |
| Net Income | -8.48M | -9.46M | -9.95M | -5.62M | -10.06M | -6.58M | -6.19M | -6.25M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -8.24M | -9.26M | -7.75M | -5.61M | -10.04M | -6.07M | -6.15M | -6.24M |
| EBITDA | -8.28M | -9.16M | -8.14M | -5.88M | -10.32M | -6.23M | -6.83M | -7.38M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 674k | 4.58M | 10.64M | 0 | 20.99M | 14.76M | 477k | 424k |
| Operating Income | -14.33M | -29.59M | -54.54M | -76.24M | -198.2M | -68.03M | -34.3M | -29.26M |
| Pre Tax Income | -14.07M | -29.08M | -51.45M | -73.7M | -255.83M | -73.78M | -33.93M | -27.87M |
| Net Income | -14.07M | -29.08M | -51.45M | -73.7M | -255.83M | -73.33M | -23.21M | -28.45M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -2.664 | -5.487 | -2.214 | -3.02 | -5.921 | -1.369 | -7.186 | -2.039 |
| EBIT | -14.33M | -29.59M | -54.54M | -76.24M | -197.09M | -68.17M | -33.93M | -27.87M |
| EBITDA | -14.33M | -29.59M | -54.51M | -76.19M | -197.86M | -67.93M | -34.22M | -29.26M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
